Wightman, in a lawsuit filed last week in BC Supreme Court, alleged the defendants did not warn him of the risk of Guillain Barre syndrome prior to administering the vaccine.
Wightman, in a lawsuit filed last week in BC Supreme Court, alleged the defendants did not warn him of the risk of Guillain Barre syndrome prior to administering the vaccine.
Wightman, in a lawsuit filed last week in BC Supreme Court, alleged the defendants did not warn him of the risk of Guillain Barre syndrome prior to administering the vaccine.
This week, Mary Holland, Children’s Health Defense (CHD) president-on-leave, and Polly Tommey, CHD.TV programming manager, covered the latest headlines on COVID-19, Big Pharma and other issues, including news that in the U.S., COVID-19 vaccines injured 26.6 million people, disabled 1.36.
Alexion, AstraZeneca Rare Disease, today announced that Health Canada has granted a Notice of Compliance (NOC) for KOSELUGO (selumetinib) for the treatment of pediatric patients aged two years and above, with neurofibromatosis type 1 (NF1) who have.